Q-LINE BIOTECH LIMITED (QLINE-SM): Q-LINE BIOTECH Share Price rises 8.57% as stock gains today
- August 31, 2026
- Posted by: Harsh Piplani
- Category: News
Q-LINE BIOTECH LIMITED share price rose 8.57% to Rs 596, lifting market capitalisation to Rs 1,280.60 Cr. Turnover stood at Rs 10.78 Cr.
Q-LINE BIOTECH Share Price rose today as the stock moved to Rs 596 from the previous close of Rs 548.95, a gain of Rs 47.05 or 8.57%. The company now has a market capitalisation of Rs 1,280.60 Cr, placing the move firmly in the day’s stock news flow. The price event is clearly confirmed by the supplied market data, while the dataset does not establish a company-specific catalyst. For readers tracking Q-LINE BIOTECH Share Price Today, the move also came with turnover of Rs 10.78 Cr, which provides a factual measure of traded value for the session. In this Univest update, the focus is on what the numbers show, how the stock compares within healthcare, and what investors can monitor next. The same data also supports a broader look at Q-LINE BIOTECH Stock News, Q-LINE BIOTECH Share Price Rise and Q-LINE BIOTECH Stock Analysis.
Q-LINE BIOTECH Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 596 |
| Previous Close | Rs 548.95 |
| Today's Move | Rs 47.05 (+8.57%) |
| Open | Rs 558 |
| High | Rs 602 |
| Low | Rs 558 |
| Turnover | Rs 10.78 crore |
| Market Capitalisation | Rs 1,280.6 crore |
| Market Cap Category | Small Cap |
Q-LINE BIOTECH LIMITED (QLINE-SM) rose to Rs 596 from the previous close of Rs 548.95, a move of Rs 47.05 or 8.57%. The stock opened at Rs 558, reached a high of Rs 602, recorded a low of Rs 558.
Q-LINE BIOTECH Share Price Today opened at Rs 558, matched the day’s low at Rs 558, and touched an intraday high of Rs 602 before settling at Rs 596. That leaves the stock Rs 47.05 above the previous close of Rs 548.95, with a day range of Rs 44 between the low and high. The price rise makes Q-LINE BIOTECH one of the notable Stocks Rising Today in the healthcare space. The session data confirms a positive price action day, and the move can be tracked on Univest as part of Q-LINE BIOTECH Share Price Live and Q-LINE BIOTECH Share Price Update coverage.
Q-LINE BIOTECH LIMITED (QLINE-SM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,280.6 crore |
| P/E Ratio | 22.98x |
| P/B Ratio | 6.05x |
| ROE | 13.94% |
| ROCE | 19.19% |
| EPS | Rs 23.89 |
| Book Value Per Share | Rs 90.75 |
| Dividend Yield | 0% |
Q-LINE BIOTECH LIMITED (QLINE-SM) fundamental metrics show P/E 22.98x, P/B 6.05x, ROE 13.94%, ROCE 19.19%. These figures provide context only and are not a buy or sell signal.
Q-LINE BIOTECH LIMITED has a market capitalisation of Rs 1280.6 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 22.98x, P/B at 6.05x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.94% and ROCE of 19.19%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 23.89, book value per share of Rs 90.75, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 29.65x, median ROE of 14%, median ROCE of 16.41%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Medical Equipment/Supplies/Accessories |
| Benchmark Scope | same industry |
| Company P/E Ratio | 22.98x |
| Benchmark Median P/E | 29.65x |
| Benchmark Average P/E | 91.19x |
| Benchmark P/E Range | 7.55x to 1,097.77x |
| Company P/B Ratio | 6.05x |
| Benchmark Median P/B | 3.19x |
| Company ROE | 13.94% |
| Benchmark Median ROE | 14% |
| Company ROCE | 19.19% |
| Benchmark Median ROCE | 16.41% |
| Company Market Capitalisation | Rs 1,280.6 crore |
| Benchmark Median Market Cap | Rs 159.81 crore |
Q-LINE BIOTECH LIMITED (QLINE-SM) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.
Q-LINE BIOTECH LIMITED (QLINE-SM) has a P/E ratio of 22.98x, which is below the benchmark median of 29.65x, a difference of -22.5%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Q-LINE BIOTECH LIMITED (QLINE-SM) has a ROE of 13.94%, which is below the benchmark median of 14%, a difference of -0.43%. Q-LINE BIOTECH LIMITED (QLINE-SM) has a ROCE of 19.19%, which is above the benchmark median of 16.41%, a difference of +16.94%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| LENSKART SOLUTIONS LTD | LENSKART | 1,10,645.96 | 168.83 | 12.38 | 6.85 | 12.55 |
| Poly Medicure Ltd. | POLYMED | 17,553.27 | 55.71 | 5.52 | 10.94 | 14.05 |
| 3B Blackbio Dx Ltd. | 3BBLACKBIO | 1,234.83 | 22.24 | 4.41 | 19.41 | 26.03 |
| LAXMI DENTAL LIMITED | LAXMIDENTL | 1,100.04 | 35.61 | 4.35 | 21.4 | 24.97 |
| Osel Devices Ltd. | OSELDEVICE | 700.57 | 23.96 | 4.26 | 30.09 | 31.15 |
Q-LINE BIOTECH LIMITED (QLINE-SM) has a P/E ratio of 22.98x compared with the displayed peer median of 35.61x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.94% compares with a peer median of 19.41% across the companies shown in the table. ROCE stood at 19.19% versus the displayed peer median of 24.97%, providing a capital-efficiency comparison. Q-LINE BIOTECH LIMITED (QLINE-SM) has a market capitalisation of Rs 1,280.6 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Q-LINE BIOTECH
- Q-LINE BIOTECH Share Price rose 8.57% today to Rs 596 from Rs 548.95.
- The session high was Rs 602 and the low was Rs 558, showing a Rs 44 intraday range.
- Market capitalisation stands at Rs 1,280.60 Cr, which places the company above the benchmark market-cap median.
- P/E is 22.98 and P/B is 6.05, both important for Q-LINE BIOTECH Fundamental Analysis.
- ROE is 13.94% and ROCE is 19.19%, which can be compared with healthcare peers on Univest.
About Q-LINE BIOTECH LIMITED
Q-LINE BIOTECH LIMITED operates in the Healthcare sector and belongs to the Medical Equipment/Supplies/Accessories industry. Based on the supplied market data, the company is positioned as a listed healthcare name with measurable earnings, book value and profitability ratios. Its financial profile includes EPS of Rs 23.89, book value of Rs 90.75 and a dividend yield of 0, which helps readers understand the current capital-market profile of the business. The stock is traded on NSE and BSE, and Q-LINE BIOTECH Company News on Univest can help readers follow the share price, valuation ratios, market capitalisation and peer positioning in one place. For investors scanning Q-LINE BIOTECH Stock News Today, the company’s identity is best understood through its industry, valuation and profit metrics rather than through speculation about unverified triggers. The same factual approach also helps frame Q-LINE BIOTECH Latest News and Q-LINE BIOTECH Share News in a neutral way.
Track Q-LINE BIOTECH Share Price on Univest
Use Q-LINE BIOTECH LIMITED (QLINE-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Q-LINE BIOTECH Share Price on Univest for live price updates, market cap, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value, shareholding pattern, 52-week levels and broader market insights. Univest also helps readers compare Q-LINE BIOTECH Stock Analysis with healthcare peers and sector benchmarks. If you follow Q-LINE BIOTECH Share Price Today regularly, the stock page is designed to keep the price action and fundamental context together in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Q-LINE BIOTECH Share Price rise today?
Ans. The supplied data confirms an 8.57% rise to Rs 596, but it does not establish a company-specific catalyst. The move is best read as verified price action alongside turnover of Rs 10.78 Cr.
What is Q-LINE BIOTECH Share Price Today?
Ans. Q-LINE BIOTECH Share Price Today is Rs 596. It moved up Rs 47.05 from the previous close of Rs 548.95 and traded between Rs 558 and Rs 602 during the session.
What is the market capitalisation of Q-LINE BIOTECH?
Ans. The company’s market capitalisation is Rs 1,280.60 Cr. That places it above the same-industry market-cap median of Rs 159.81 Cr, though size alone does not indicate quality or future performance.
How are Q-LINE BIOTECH valuation ratios positioned?
Ans. Q-LINE BIOTECH trades at a P/E of 22.98 and a P/B of 6.05. EPS is Rs 23.89 and book value is Rs 90.75, giving investors a direct valuation reference. The company trades at a P/E ratio of 22.98x.
How do ROE and ROCE look for Q-LINE BIOTECH?
Ans. ROE stands at 13.94% and ROCE at 19.19%. ROE is close to the industry median of 14%, while ROCE is above the sector median of 16.41% and average of 17.66%.
How does Q-LINE BIOTECH compare with peers?
Ans. Compared with listed peers, Q-LINE BIOTECH has a lower P/E than Poly Medicure and Lenskart, but higher P/B than several peers. Its profitability sits near the industry benchmark, with ROCE above average.
Where can readers track Q-LINE BIOTECH Share Price?
Ans. Readers can track Q-LINE BIOTECH Share Price on Univest for live price updates, valuation ratios, shareholding pattern, 52-week levels and sector context. The stock page keeps the latest price data and analysis together.
